Stratos Wealth Partners, LTD. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Stratos Wealth Partners, LTD. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q4 2022$285,652
+2.4%
5,604
+8.2%
0.01%
-12.5%
Q3 2022$279,000
-25.2%
5,179
-10.8%
0.01%
-11.1%
Q2 2022$373,000
-16.4%
5,806
+1.0%
0.01%
-10.0%
Q1 2022$446,000
-10.1%
5,748
-0.4%
0.01%
-9.1%
Q4 2021$496,000
+1.0%
5,772
-5.4%
0.01%
-8.3%
Q3 2021$491,000
+0.2%
6,104
+0.3%
0.01%0.0%
Q2 2021$490,000
-6.1%
6,086
-1.7%
0.01%
-14.3%
Q1 2021$522,000
+4.0%
6,193
-1.1%
0.01%
-6.7%
Q4 2020$502,000
+5.7%
6,261
+6.1%
0.02%
-6.2%
Q3 2020$475,000
-12.2%
5,900
-6.1%
0.02%
-15.8%
Q2 2020$541,000
+6.1%
6,281
+0.0%
0.02%
-17.4%
Q1 2020$510,000
+4.3%
6,278
+7.3%
0.02%
+21.1%
Q4 2019$489,000
-17.3%
5,852
-13.4%
0.02%
-26.9%
Q3 2019$591,000
+0.2%
6,756
-6.2%
0.03%0.0%
Q2 2019$590,000
-2.5%
7,203
-3.2%
0.03%
-3.7%
Q1 2019$605,000
+33.8%
7,441
+8.4%
0.03%
+17.4%
Q4 2018$452,000
-26.9%
6,865
-18.0%
0.02%
-17.9%
Q2 2018$618,000
+2.7%
8,372
-9.6%
0.03%
+12.0%
Q1 2018$602,000
-16.3%
9,264
-16.7%
0.02%
-21.9%
Q4 2017$719,000
+5.3%
11,116
+2.2%
0.03%0.0%
Q3 2017$683,000
+19.8%
10,878
-15.3%
0.03%
-8.6%
Q4 2016$570,000
-16.7%
12,847
-10.6%
0.04%
-23.9%
Q3 2016$684,000
+45.2%
14,366
+37.8%
0.05%
+31.4%
Q2 2016$471,000
+1.7%
10,422
-14.2%
0.04%
-10.3%
Q4 2015$463,000
-12.5%
12,140
+65.1%
0.04%
-77.8%
Q2 2014$529,0007,3550.18%
Other shareholders
BAXTER INTL INC shareholders Q2 2022
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders